77
Views
0
CrossRef citations to date
0
Altmetric
Papers

Differential transcription of matrix-metalloproteinase genes in primary mouse astrocytes and microglia infected with Theiler's murine encephalomyelitis virus

, , , , , & show all
Pages 205-217 | Received 30 Nov 2007, Accepted 13 Feb 2008, Published online: 10 Jul 2009

References

  • Alldinger S, Gröters S, Miao Q, Fonfara S, Kremmer E, Baumgärtner W. Roles of an extracellular matrix (ECM) receptor and ECM processing enzymes in demyelinating canine distemper encephalitis. Dtsch tierärztl Wschr 2006; 113: 151–168
  • Aubert C, Chamorro M, Brahic M. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathogen 1987; 3: 319–326
  • Baker A H, Edwards D R, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002; 115: 3719–3727
  • Bottenstein J E, Sato G H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci U S A 1979; 76: 514–517
  • Brahic M. Theiler's virus infection of the mouse, or: of the importance of studying animal models. Virology 2002; 301: 1–5
  • Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1(477)267–283
  • Carpentier P A, Williams B R. Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia 2007; 55: 239–252
  • Chandler S, Cossins J, Lury J, Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun 1996; 228: 421–429
  • Clements J M, Cossins J A, Wells G M, Corkill D J, Helfrich K, Wood L M, Pigott R, Stabler G, Ward G A, Gearing A J, Miller K M. Matrix metalloproteinases expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J Neuroimmunol 1997; 74: 85–94
  • Cossins J A, Clements J M, Ford J, Miller K M, Pigott R, Vos W, van der Valk P, de Groot C J. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 1997; 94: 590–598
  • Crocker S J, Milner R, Pham-Mitchell N, Campbell I L. Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells. J Neurochem 2006; 98: 812–823
  • Cuzner M L, Opdenakker G. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol 1999; 94: 1–14
  • Dal Canto M C, Lipton H L. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pathol 1982; 106: 20–29
  • Gerhauser I, Alldinger S, Baumgärtner W. Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis. J Neuroimmunol 2007a; 188: 86–94
  • Gerhauser I, Alldinger S, Ulrich R, Baumgärtner W. Spatio-temporal expression of immediate early genes in the central nervous system of SJL/J mice. Int J Dev Neurosci 2005; 23: 637–649
  • Gerhauser I, Ulrich R, Alldinger S, Baumgärtner W. Induction of activator protein-1 and nuclear factor-κB as a prerequisite for disease development in susceptible SJL/J mice after Theiler murine encephalomyelitis. J Neuropathol Exp Neurol 2007b; 66: 809–818
  • Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell R A, Diamond M S, Colonna M. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006; 103: 8459–8464
  • Giulian D, Baker T J. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 1986; 6: 2163–2178
  • Gottschall P E, Yu X, Bing B. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 1995; 42: 335–342
  • Gronski T J, Martin R L, Kobayashi D K, Walsh B C, Holman M C, Huber M, Van Wart H E, Shapiro S D. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem 1997; 272: 12189–12194
  • Gröters S, Alldinger S, Baumgärtner W. Up-regulation of mRNA for matrix metalloproteinases-9 and -14 in advanced lesions of demyelinating canine distemper leukoencephalitis. Acta Neuropathol 2005; 110: 369–382
  • Hartung H P, Kieseier B C. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 2000; 107: 140–147
  • Im H J, Muddasani P, Natarajan V, Schmid T M, Block J A, David F, van Wijnen A J, Loeser R F. Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between mitogen activated protein kinases and protein kinase Cδ pathways in human adult articular chondrocytes. J Biol Chem 2007; 282: 11110–11121
  • Jaworski D M. Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury. Glia 2000; 30: 199–208
  • Jelachich M L, Bramlage C, Lipton H L. Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis. J Virol 1999; 73: 3227–3235
  • Khasigov P Z, Podobed O V, Ktzoeva S A, Gatagonova T M, Grachev S V, Shishkin S S, Berezov T T. Matrix Metalloproteinases of normal human tissues. Biochemistry 2001; 66: 130–140
  • Kieseier B C, Paul R, Koedel U, Seifert T, Clements J M, Gearing A J, Pfister H W, Hartung H P. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 1999; 122: 1579–1587
  • Leppert D, Lindberg R L, Kappos L, Leib S L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev 2001; 36: 249–257
  • Lindberg R LP, De Groot C JA, Montagne L, Freitag P, der van Valk P, Kappos L, Leppert D. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 2001; 124: 1743–1753
  • Lipton H L. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun 1975; 11: 1147–1155
  • Lipton H L, Twaddle G, Jelachich M L. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 1995; 69: 2525–2533
  • Liuzzi G M, Latronico T, Fasabo A, Carlone G, Riccio P. Interferon-beta inhibits the expression of metalloproteinases in rat glial culture implications for multiple sclerosis pathogenesis and treatment. Mult Scler 2004; 10: 290–297
  • Ma Z, Qin H, Benveniste E N. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 2001; 167: 5150–5159
  • Markus S, Failing K, Baumgärtner W. Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. J Neuroimmunol 2002; 125: 30–41
  • Massova I, Kotra L P, Fridman R, Mobasery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 1998; 12: 1075–1095
  • Matrisian L M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121–125
  • McCarthy K D, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980; 85: 890–902
  • McCawley L J, Matrisian L M. Matrix metalloproteinases: they're not just for matrix anymore. Curr Opin Cell Biol 2001; 13: 534–540
  • Miao Q, Baumgärtner W, Failing K, Alldinger S. Phase-dependent expression of matrix metalloproteinases and their inhibitors in demyelinating canine distemper encephalitis. Acta Neuropathol 2003; 106: 486–494
  • Mun-Bryce S, Lukes A, Wallace J, Lukes-Marx M, Rosenberg G A. Stromelysin-1 and gelatinase A are upregulated before TNF-[alpha] in LPS-stimulated neuroinflammation. Brain Res 2002; 933: 42–49
  • Neuhold L A, Killar L, Zhao W, Sung M LA, Warner L, Kulik J, Turner J, Wu W, Billinghurst C, Meijers T, Poole A R, Babij P, DeGennaro L J. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001; 107: 35–44
  • Oleszak E L, Chang J R, Friedman H, Katsetos C D, Platsoucas C D. Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev 2004; 17: 174–207
  • Pagenstecher A, Stalder A K, Kincaid C L, Shapiro S D, Campbell I L. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 1998; 152: 729–741
  • Palma J P, Kim B S. The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus. J Neuroimmunol 2004; 149: 121–129
  • Palma J P, Kwon D, Clipstone N A, Kim B S. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease. J Virol 2003; 77: 6322–6331
  • Racaniello V R. Picornaviridae: the viruses and their replication. Field's virology, D M Knipe, P M Howley, D E Griffin, R A Lamb, M A Martin, B Roizman, S E Strauss. Lippincott Williams & Wilkins, Philadelphia 2001; 685–722
  • Ries C, Petrides P E. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995; 376: 345–355
  • Rosenberg G A. Matrix metalloproteinases in multiple sclerosis: is it time for a treatment trial?. Ann Neurol 2001; 50: 431–433
  • Rosenberg G A. Matrix metalloproteinases in neuroinflammation. Glia 2002; 39: 279–291
  • Rosenberg G A. Matrix metalloproteinases biomarkers in multiple sclerosis. Lancet 2005; 365: 1291–1293
  • Rosenberg G A, Estrada E Y, Dencoff J E, Stetler-Stevenson W G. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 1995; 703: 151–155
  • Rozhon E J, Kratochvil J D, Lipton H L. Analysis of genetic variation in Theiler's virus persistent infection in the mouse central nervous system. Virology 1983; 128: 16–32
  • Rubio N, Capa L. Differential IL-1 synthesis by astrocytes from Theiler's murine encephalomyelitis virus-susceptible and -resistant strains of mice. Cell Immunol 1993; 149: 237–247
  • Rubio N, Martin-Clemente B. Theiler's murine encephalomyelitis virus infection induces early expression of c-fos in astrocytes. Virology 1999; 258: 21–29
  • Rubio N, Sanz-Rodriguez F, Lipton H L. Theiler's virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains. Cell Immunol 2006; 239: 31–40
  • Rudolph-Owen L A, Hulboy D L, Wilson C L, Mudgett J, Matrisian M. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology 1997; 138: 4902–4911
  • So E Y, Kang M H, Kim B S. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. Glia 2006; 53: 858–867
  • Stamenkovic I. Extracellular matrix remodeling: the role of matrix metalloproteinases. J Pathol 2003; 200: 448–464
  • Stohlman S A, Hinton D R. Viral induced demyelination. Brain Pathol 2001; 11: 92–106
  • Teesalu T, Hinkkanen A E, Vaheri A. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am J Pathol 2001; 159: 2227–2237
  • Theiler M. Spontaneous encephalomyelitis of mice—a new virus disease. Science 1934; 80: 122–123
  • Thorns V, Walter G F, Thorns C. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 2003; 23: 3937–3944
  • Toft-Hansen H, Nuttall R K, Edwards D R, Owens T. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol 2004; 173: 5209–5218
  • Tsunoda I, Iwasaki Y, Terunuma H, Sako K, Ohara Y. A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus. Acta Neuropathol 1996; 91: 595–602
  • Ulrich R, Baumgärtner W, Gerhauser I, Seeliger F, Haist V, Deschl U, Alldinger S. MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating Theiler murine encephalomyelitis. J Neuropathol Exp Neurol 2006; 65: 783–793
  • Ulrich R, Gerhauser I, Seeliger F, Baumgärtner W, Alldinger S. Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study. Dev Neurosci 2005; 27: 408–418
  • Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3, published online: http://genomebiology.com/2002/3/7/research/0034
  • Vos C M, van Haastert E S, de Groot C J, van der Valk P, de Vries H E. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmunol 2003; 138: 106–114
  • Welsh C J, Tonks P, Borrow P, Nash A A. Theiler's virus: an experimental model of virus-induced demyelination. Autoimmunity 1990; 6: 105–112
  • Woessner J F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145–2153
  • Yong V W, Krekoski C A, Forsyth P A, Bell R, Edwards D R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998; 21: 75–80
  • Zheng L, Calenoff M A, Dal Canto M C. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J Neuroimmunol 2001; 118: 256–267
  • Zhou J, Marten N W, Bergmann C C, Macklin W B, Hinton D R, Stohlman S A. Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. J Virol 2005; 79: 4764–4773
  • Zhou J, Stohlman S A, Atkinson R, Hinton D R, Marten N W. Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection. J Virol 2002; 76: 7374–7384
  • Zoecklein L J, Pavelko K D, Gamez J, Papke L, McGavern D B, Ure D R, Njenga M K, Johnson A J, Nakane S, Rodriguez M. Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus. Brain Pathol 2003; 13: 291–308

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.